187 related articles for article (PubMed ID: 12357269)
21. Screening and follow-up of the patient at high risk for breast cancer.
Willey SC; Cocilovo C
Obstet Gynecol; 2007 Dec; 110(6):1404-16. PubMed ID: 18055740
[TBL] [Abstract][Full Text] [Related]
22. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316
[No Abstract] [Full Text] [Related]
23. [Interview with Prof. Dr. Wolfgang Eiermann. Which women need a medicamentous breast cancer prophylaxis?].
Eiermann W
MMW Fortschr Med; 2003 Dec; 145(50):8. PubMed ID: 14963963
[No Abstract] [Full Text] [Related]
24. Chemoprevention of breast cancer for women at high risk.
Chan K; Morris GJ
Semin Oncol; 2006 Dec; 33(6):642-6. PubMed ID: 17145342
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic mastectomy.
Zakaria S; Degnim AC
Surg Clin North Am; 2007 Apr; 87(2):317-31, viii. PubMed ID: 17498529
[TBL] [Abstract][Full Text] [Related]
26. [Primary prevention of breast cancer in women with an increased risk for breast cancer--a prospective, randomized, double-blind study (NSABP-P1 study)].
Reichert D; Illiger HJ
Strahlenther Onkol; 2000 Jan; 176(1):43-4. PubMed ID: 10650836
[No Abstract] [Full Text] [Related]
27. Chemoprevention trends in breast cancer.
Lazzaro M; Mizell V; Thompson M; Weber D
Adv Nurse Pract; 1998 Nov; 6(11):26-8, 33-4, 74. PubMed ID: 9919058
[No Abstract] [Full Text] [Related]
28. "I'm going to die of something anyway": women's perceptions of tamoxifen for breast cancer risk reduction.
Paterniti DA; Melnikow J; Nuovo J; Henderson S; DeGregorio M; Kuppermann M; Nease R
Ethn Dis; 2005; 15(3):365-72. PubMed ID: 16108294
[TBL] [Abstract][Full Text] [Related]
29. Prophylaxis approach to a-symptomatic post-menopausal women: breast cancer.
Aguas F; Martins A; Gomes TP; de Sousa M; Silva DP;
Maturitas; 2005 Nov; 52 Suppl 1():S23-31. PubMed ID: 16126355
[TBL] [Abstract][Full Text] [Related]
30. [Chemoprevention of breast cancer. Clinical trials in pharmacological prevention].
Ricart JJ
Medicina (B Aires); 2004; 64(1):66-72. PubMed ID: 15034961
[TBL] [Abstract][Full Text] [Related]
31. [Breast cancer prevention: from chemoprevention to prophylactic surgery].
Morcel K; Rouquette S; Dugast C; Bendavid C; Audrain O; Levêque J
J Gynecol Obstet Biol Reprod (Paris); 2008 Nov; 37(7):661-71. PubMed ID: 18653291
[TBL] [Abstract][Full Text] [Related]
32. Chemoprevention or mastectomy for women at high risk of developing breast cancer.
Sismondi P; D'Alonzo M; Pecchio S; Bounous VE; Robba E; Biglia N
Maturitas; 2015 Nov; 82(3):271-3. PubMed ID: 26276104
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer. Dissecting a hidden breast cancer risk.
Couzin J
Science; 2005 Sep; 309(5741):1664-6. PubMed ID: 16150987
[No Abstract] [Full Text] [Related]
34. [Chemoprevention of breast cancer: a literature review and report on the current status in Germany].
Paepke S; V Minckwitz G; Kaufmann M; Schwarz-Boeger U; Jacobs VR; Aigner M; Pfeifer K; Ehmer M; Hüttner C; Blohmer JU; Kiechle M
Zentralbl Gynakol; 2003 Sep; 125(9):338-45. PubMed ID: 14569515
[TBL] [Abstract][Full Text] [Related]
35. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits.
Brewster AM; Christo DK; Lai H; Helzlsouer K
Cancer; 2005 Mar; 103(6):1147-53. PubMed ID: 15674856
[TBL] [Abstract][Full Text] [Related]
36. Contralateral prophylactic mastectomy for patients with unilateral breast cancer.
Tuttle T; Habermann E; Abraham A; Emory T; Virnig B
Expert Rev Anticancer Ther; 2007 Aug; 7(8):1117-22. PubMed ID: 18028020
[TBL] [Abstract][Full Text] [Related]
37. Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy.
Veronesi U; Maisonneuve P; Rotmensz N; Bonanni B; Boyle P; Viale G; Costa A; Sacchini V; Travaglini R; D'Aiuto G; Oliviero P; Lovison F; Gucciardo G; del Turco MR; Muraca MG; Pizzichetta MA; Conforti S; Decensi A;
J Natl Cancer Inst; 2007 May; 99(9):727-37. PubMed ID: 17470740
[TBL] [Abstract][Full Text] [Related]
38. The prevention of hereditary breast cancer.
Rodriquez E; Domchek SM
Semin Oncol; 2007 Oct; 34(5):401-5. PubMed ID: 17920894
[TBL] [Abstract][Full Text] [Related]
39. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM
J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980
[TBL] [Abstract][Full Text] [Related]
40. Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
Phillips KA; Jenkins MA; Lindeman GJ; McLachlan SA; McKinley JM; Weideman PC; Hopper JL; Friedlander ML;
Clin Genet; 2006 Sep; 70(3):198-206. PubMed ID: 16922722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
